5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-fluorophenyl)-1,2,4-oxadiazole

ID: ALA4868264

PubChem CID: 164618862

Max Phase: Preclinical

Molecular Formula: C11H7BrFN3O2

Molecular Weight: 312.10

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccc(-c2noc(C3CC(Br)=NO3)n2)cc1

Standard InChI:  InChI=1S/C11H7BrFN3O2/c12-9-5-8(17-15-9)11-14-10(16-18-11)6-1-3-7(13)4-2-6/h1-4,8H,5H2

Standard InChI Key:  LXTVSNROJVZILL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   22.5614  -10.5038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8503  -10.9065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1069  -10.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5551  -11.1759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9578  -11.8870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7585  -11.7236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7431  -11.0838    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   23.3059  -10.8353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8527  -10.2280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4441   -9.5202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6448   -9.6903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.6654  -10.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9933  -11.0592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8052  -11.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2864  -10.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9499   -9.7340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1389   -9.6519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0992  -10.5677    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  6  1  0
  4  7  1  0
  1  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  1  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4868264

    ---

Associated Targets(non-human)

Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania tropica (461 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 312.10Molecular Weight (Monoisotopic): 310.9706AlogP: 3.05#Rotatable Bonds: 2
Polar Surface Area: 60.51Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.39CX LogD: 3.39
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.85Np Likeness Score: -1.75

References

1. Galbiati A, Zana A, Coser C, Tamborini L, Basilico N, Parapini S, Taramelli D, Conti P..  (2021)  Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds.,  12  (11.0): [PMID:34795860] [10.1021/acsmedchemlett.1c00354]

Source